In recent trading session, Aptose Biosciences Inc (NASDAQ:APTO) saw 149.4 million shares changing hands at last check today with its beta currently measuring 1.08. Company’s recent per share price level of $0.19 trading at $0.04 or 26.15% at last check today assigns it a market valuation of $11.38M. That most recent trading price of APTO’s stock is at a discount of -957.89% from its 52-week high price of $2.01 and is indicating a premium of 31.58% from its 52-week low price of $0.13.

For Aptose Biosciences Inc (APTO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Aptose Biosciences Inc (NASDAQ:APTO) trade information

Upright in the green today for gaining 26.15%, in the last five days APTO remained trading in the red while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $0.19 price level, adding 25.49% to its value on the day. Aptose Biosciences Inc’s shares saw a change of -16.07% in year-to-date performance and have moved -17.35% in past 5-day. Aptose Biosciences Inc (NASDAQ:APTO) showed a performance of -13.14% in past 30-days.

Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders

DOHENY ASSET MANAGEMENT /CA is the top institutional holder at APTO for having 50550.0 shares of worth $0.32 million. And as of 2024-06-30, it was holding 0.3849 of the company’s outstanding shares.

The second largest institutional holder is CALDWELL SUTTER CAPITAL, INC., which was holding about 92.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.0007 of outstanding shares, having a total worth of $70.0.